Academic literature on the topic 'Coronary heart disease – Chemotherapy'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Coronary heart disease – Chemotherapy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Coronary heart disease – Chemotherapy"

1

Palmer, S. C., J. Carver, L. Jacobs, et al. "Assessment of coronary heart disease risk in testicular cancer survivors." Journal of Clinical Oncology 24, no. 18_suppl (2006): 4592. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.4592.

Full text
Abstract:
4592 Background: Testicular cancer survivors (TCS) who receive cisplatin-based chemotherapy (CBCT) are reported to have an increased risk of coronary heart disease (CHD) compared to chemo-naive TCS (J Clin Oncol 21:1513–1523, 2003). We hypothesized that TCS treated with CBCT would demonstrate abnormal objective measures of future CHD risk compared to chemo-naive TCS. Methods: TCS ≥ 2 years from diagnosis underwent evaluation using established objective measures predictive of future CHD risk: body mass index (BMI), Framingham relative risk (RR), flow-mediated endothelium-dependent vasodilation
APA, Harvard, Vancouver, ISO, and other styles
2

Сергеева, N. Sergeeva, Коломиец, et al. "Evaluation of Spent Pharmacotherapy in the Patients with Coronary Heart Disease Associated with Pulmonary Tuberculosis by means of the Neural Network." Journal of New Medical Technologies 21, no. 4 (2014): 108–12. http://dx.doi.org/10.12737/7281.

Full text
Abstract:
Current, the programs of mass prevention of the cardiovascular diseases, based on preventive medicinal correction of risk factors of cardiovascular diseases, such as hyperlipidemia, arterial hypertension, diabetes mellitus, are developed and realized.
 Pulmonary tuberculosis influences on state of blood system, which can be considered as functional disorders of the cardiovascular system caused by tuberculosis. These violations caused by concomitant tuberculosis lung diseases, such as cardiovascular and other diseases of the respiratory system. Specific (tuberculosis) damages of the heart
APA, Harvard, Vancouver, ISO, and other styles
3

Bachmeyer, Claude, Hervé Joly, and Roland Jorest. "Early Myocardial Infarction during Chemotherapy for Testicular Cancer." Tumori Journal 86, no. 5 (2000): 428–30. http://dx.doi.org/10.1177/030089160008600513.

Full text
Abstract:
A 36-year-old man with testicular cancer had an acute myocardial infarction during the first course of chemotherapy with bleomycin, etoposide and cisplatin. Since the patient had no significant risk factors for coronary heart disease, the infarction was likely to be attributable to the chemotherapy regimen. The physiopathological mechanisms of this causal relationship are discussed here.
APA, Harvard, Vancouver, ISO, and other styles
4

Ozben, Beste, Ramazan Kurt, Huseyin Oflaz, et al. "Acute Anterior Myocardial Infarction After Chemotherapy for Testicular Seminoma in a Young Patient." Clinical and Applied Thrombosis/Hemostasis 13, no. 4 (2007): 439–42. http://dx.doi.org/10.1177/1076029607303334.

Full text
Abstract:
Testicular cancer is the most common solid tumor among young men aged 15 to 35 years. Combination chemotherapy with cisplatin, etoposide, and bleomycin remains the mainstay of treatment. We present a 27-year-old man who presented with an acute anterior myocardial infarction during the second course of chemotherapy for seminoma. Because the patient had no significant risk factors for coronary heart disease, the infarction was likely caused by the chemotherapy regimen.
APA, Harvard, Vancouver, ISO, and other styles
5

Hader, Shelby N., Natalya Zinkevich, Laura E. Norwood Toro, et al. "Detrimental effects of chemotherapy on human coronary microvascular function." American Journal of Physiology-Heart and Circulatory Physiology 317, no. 4 (2019): H705—H710. http://dx.doi.org/10.1152/ajpheart.00370.2019.

Full text
Abstract:
Chemotherapy (CT) is a necessary treatment to prevent the growth and survival of cancer cells. However, CT has a well-established adverse impact on the cardiovascular (CV) system, even years after cessation of treatment. The effects of CT drugs on tumor vasculature have been the focus of much research, but little evidence exists showing the effects on the host microcirculation. Microvascular (MV) dysfunction is an early indicator of numerous CV disease phenotypes, including heart failure. The goal of this study was to evaluate the direct effect of doxorubicin (Dox) on human coronary MV functio
APA, Harvard, Vancouver, ISO, and other styles
6

Zhang, Dingguo, Liansheng Wang, and Zhijian Yang. "Recurrent Syncope Associated with Lung Cancer." Case Reports in Medicine 2015 (2015): 1–4. http://dx.doi.org/10.1155/2015/309784.

Full text
Abstract:
Syncope is an important problem in clinical practice with many possible causes that might be misdiagnosed. We present an unusual case of syncope, which has a normal chest X-ray. Exercise EKG and coronary angioplasty results confirmed the existence of serious coronary heart disease. The patient was treated with coronary stent transplantation. However, scope occurred again and the elevated tumor makers cytokeratin-19-fragment and neuron-specific enolase revealed the bronchogenic carcinoma, which was confirmed by enhanced CT examination. The treatment of carcinoma by chemotherapy was indeed suffi
APA, Harvard, Vancouver, ISO, and other styles
7

Daher, Iyad N., Jose Banchs, Syed Wamique Yusuf, Elie Mouhayar, Jean-Bernard Durand, and Gregory Gladish. "Impact of Cardiac Computed Tomographic Angiography Findings on Planning of Cancer Therapy in Patients with Concomitant Structural Heart Disease." Cardiology Research and Practice 2011 (2011): 1–7. http://dx.doi.org/10.4061/2011/268058.

Full text
Abstract:
Background. Exclusion of underlying coronary artery disease (CAD) is essential in the diagnosis of chemotherapy-induced cardiomyopathy. Presence and severity of CAD can also impact the choice of therapy in cancer patients. The value of cardiac computed tomographic angiography (CCTA) in this setting has not been reported.Methods. We collected data on the clinical presentation and indications for CCTA performed from January to December 2008 at the University of Texas MD Anderson Cancer Center (MDACC). All examinations were performed using a 64-detector scanner. CCTA results and subsequent treatm
APA, Harvard, Vancouver, ISO, and other styles
8

van Leeuwen, Flora E., and Andrea K. Ng. "Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment." Hematology 2016, no. 1 (2016): 323–30. http://dx.doi.org/10.1182/asheducation-2016.1.323.

Full text
Abstract:
Abstract Long-term survivors of Hodgkin lymphoma (HL) experience several late adverse effects of treatment, with second malignant neoplasms (SMNs) and cardiovascular diseases (CVDs) being the leading causes of death in these patients. Other late effects have also been identified, such as pulmonary dysfunction, endocrinopathies (thyroid dysfunction, infertility), neck muscle atrophy, and persistent fatigue. HL survivors have two- to fourfold increased risks to develop SMNs and CVD compared with the general population. With respect to SMNs, radiotherapy is associated with 1.5- to 15-fold increas
APA, Harvard, Vancouver, ISO, and other styles
9

Chaulin, A. M., and D. V. Duplyakov. "Increased natriuretic peptides not associated with heart failure." Russian Journal of Cardiology 25 (January 11, 2021): 4140. http://dx.doi.org/10.15829/1560-4071-2020-4140.

Full text
Abstract:
Natriuretic peptides (NPs) are key diagnostic and prognostic biomarkers for patients with heart failure (HF). The main mechanism for increasing serum NP levels, which is characteristic of heart failure, is secretion in response to myocardial wall distention. At the same time, according to Russian and foreign literature, an increase in NPs is reported in a number of many other conditions that are not associated with HF. The study of these causes and mechanisms is necessary to improve the differential diagnosis of HF.This article discusses the mechanisms of increasing NPs and their diagnostic va
APA, Harvard, Vancouver, ISO, and other styles
10

Karev, E. A., S. L. Verbilo, E. G. Malev, et al. "Myocardial strain echocardiographic assessment: from theory to practice." Translational Medicine 7, no. 6 (2020): 16–28. http://dx.doi.org/10.18705/2311-4495-2020-7-6-16-28.

Full text
Abstract:
Assessment of systolic and diastolic ventricular function is one of the main goals of echocardiography. Nevertheless, some patients require data beyond standard echocardiographic protocol for making more precise clinical decision and prognosis determination. The spectrum of novel parameters, including myocardial strain and strain rate, provides more comprehensive evaluation of the initial changes in myocardium in a variety of clinical conditions. New methods of quantifying the systolic function of left and right ventricles can be applied in patients with arterial hypertension, coronary heart d
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Coronary heart disease – Chemotherapy"

1

Dorn, Karen Toft. "Circulatory, hormonal, and metabolic effects of arbutamine compared to exercise in persons with known or suspected coronary artery disease." Diss., Virginia Tech, 1994. http://hdl.handle.net/10919/38284.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Dane-Stewart, Cheryl Ann. "Postprandial lipoprotein metabolism in patients at high risk of coronary artery disease : effects of statin therapy." University of Western Australia. School of Medicine and Pharmacology, 2003. http://theses.library.uwa.edu.au/adt-WU2004.0061.

Full text
Abstract:
[Formulae and special characters can only be approximated here. Please see the pdf version of the abstract for an accurate reproduction.] Atherosclerosis is a common degenerative disease in which the clinical manifestations are often through stroke or myocardial infarction. Some of the established risk factors for atherosclerosis include elevated plasma low-density lipoprotein (LDL)-cholesterol levels, obesity, diabetes mellitus (DM) and cigarette smoking. Of the risk factors, an elevation in plasma LDL is one of the most established and the most researched. This is partly a consequence of
APA, Harvard, Vancouver, ISO, and other styles
3

Brouilette, Scott Wayne. "Telomeres and coronary heart disease." Thesis, University of Leicester, 2004. http://hdl.handle.net/2381/29899.

Full text
Abstract:
Using mean telomere length as a marker of biological age, I show that: 1. Subjects with premature myocardial infarction (MI) have significantly shorter telomeres than age-sex matched, healthy, controls. The mean telomere length in MI subjects was similar to controls almost 11 years older. 2. Healthy young adult children of families with a strong history of premature MI have shorter telomeres than age matched children of families without such a history. 3. Shorter telomere lengths are associated with increase risk of subsequent CHD events in a prospective study. This analysis was carried out on
APA, Harvard, Vancouver, ISO, and other styles
4

Lee, Chi-hang. "Microvascular obstruction following percutaneous coronary intervention for coronary artery disease." Click to view the E-thesis via HKUTO, 2009. http://sunzi.lib.hku.hk/hkuto/record/B43278723.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Danesh, John. "Chronic infection and coronary heart disease." Thesis, University of Oxford, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.326020.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kounali, Daphne. "Early growth and coronary heart disease." Thesis, University of Southampton, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.436926.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Heiser, Claire Anne. "Personality predictors of coronary heart disease." Thesis, Virginia Polytechnic Institute and State University, 1985. http://hdl.handle.net/10919/50027.

Full text
Abstract:
Fifty percent of the diagnosed cases of coronary heart disease in the United States are of unknown etiology. This study proposed that five personality traits— achievement, dominance, aggression, succorance and Critical Parent—differentiate individuals with coronary heart disease manifestations. The ultimate goal of this research was to formulate a predictive profile of at-risk individuals of developing coronary heart disease. Cardiac rehabilitation units' participants from across the United States were recruited as subjects. Randomly selected cardiac rehabilitation units were sent an initial
APA, Harvard, Vancouver, ISO, and other styles
8

Lee, Chi-hang, and 李志恆. "Microvascular obstruction following percutaneous coronary interventionfor coronary artery disease." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2009. http://hub.hku.hk/bib/B43278723.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Zapanta, Laurence (Laurence F. ). "Heart rate variability in mice with coronary heart disease." Thesis, Massachusetts Institute of Technology, 2005. http://hdl.handle.net/1721.1/34118.

Full text
Abstract:
Thesis (S.M.)--Massachusetts Institute of Technology, Dept. of Electrical Engineering and Computer Science, 2005.<br>Includes bibliographical references (leaves 69-71).<br>Heart rate variability (HRV), the beat-to-beat fluctuation of the heart rate, is a non-invasive test that measures the autonomic regulation of the heart. Assessment of HRV has been shown to predict the risk of mortality in patients after an acute myocardial infarction. Recently, the Krieger lab at MIT developed genetically engineered double knockout (dKO) mice that develop coronary artery disease accompanied by spontaneous m
APA, Harvard, Vancouver, ISO, and other styles
10

Rose, Edward Leslie. "Coronary heart disease in patients with peripheral vascular disease." Thesis, University of Oxford, 1991. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.305544.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Coronary heart disease – Chemotherapy"

1

International, Symposium on Molsidomine (1984 Düsseldorf Germany). Ischemic heart disease and heart failure: Advances in treatment with molsidomine. Urban & Schwarzenberg, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

R, Lichtlen Paul, ed. New therapy of ischaemic heart disease and hypertension: Proceedings of the symposium held in Geneva, 18-20 April 1985. Excerpta Medica, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Workshop on Nisoldipine in Coronary Artery Diseases and Myocardial Infarction (1992 London). Workshop on nisoldipine in coronary artery diseases and myocardial infarction: Papers presented at a workshop held in London, April 8, 1992, during the International Conference on Acute Myocardial Infarction. Raven Health Care Communications, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Questions from the heart: Answers to 100 questions about Chelation therapy, a safe alternative to bypass surgery. Hampton Roads Pub., 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kendall, Martin J. Preventing coronary artery disease: Cardioprotective therapeutics in practice. 2nd ed. Martin Dunitz, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

N, Cohn Jay, and Rittinghausen R, eds. Mononitrates: [International Symposium on Mononitrates, Montreux, Switzerland, June 14-16, 1984]. Springer-Verlag, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Schneeweiss, Adam. Advances in nitrate therapy. 2nd ed. Springer-Verlag, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Schneeweiss, Adam. Advances in nitrate therapy. Springer-Verlag, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Cranton, Elmer M. Xiang tong bo zai shuo bu: Gen zhi wan zheng de qu du liao fa = Bypassing bypass surgery. Tian chuang chu ban she you xian gong si, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Clopidogrel response in acute coronary syndrome: Clinical implications and emerging therapies. Nova Science Publishers, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Coronary heart disease – Chemotherapy"

1

Slanina, Joachim, Karl Henne, Norbert Hodapp, Gisela Moog, and Hermann Frommhold. "Cardiotoxicity After Megavoltage Irradiation and Chemotherapy for Hodgkin’s Disease with Special Emphasis on Coronary Heart Disease Mortality — The Freiburg Experience 1940–1992." In Late Sequelae in Oncology. Springer Berlin Heidelberg, 1995. http://dx.doi.org/10.1007/978-3-642-46794-3_25.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Bergersen, Lisa, Susan Foerster, Audrey C. Marshall, and Jeffery Meadows. "Coronary Angiography." In Congenital Heart Disease. Springer US, 2009. http://dx.doi.org/10.1007/978-0-387-77292-9_23.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Abdelhafiz, Ahmed H. "Coronary heart disease." In Diabetes in Old Age. John Wiley & Sons, Ltd, 2017. http://dx.doi.org/10.1002/9781118954621.ch7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Schenck-Gustafsson, Karin. "Coronary Heart Disease." In Handbook of Clinical Gender Medicine. KARGER, 2012. http://dx.doi.org/10.1159/000336385.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kalmar, Jayne M., Brigid M. Lynch, Christine M. Friedenreich, et al. "Coronary Heart Disease." In Encyclopedia of Exercise Medicine in Health and Disease. Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-540-29807-6_51.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Tsuboi, Hirohito, Katsunori Kondo, Hiroshi Kaneko, and Hiroko Yamamoto. "Coronary Heart Disease." In Social Determinants of Health in Non-communicable Diseases. Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-1831-7_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Feuerstein, Michael, Elise E. Labbé, and Andrzej R. Kuczmierczyk. "Coronary Heart Disease." In Health Psychology. Springer US, 1986. http://dx.doi.org/10.1007/978-1-4899-0562-8_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Gorog, Diana. "Coronary Heart Disease." In The Interventional Cardiology Training Manual. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-71635-0_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Whang, William. "Coronary Heart Disease." In Encyclopedia of Behavioral Medicine. Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4419-1005-9_396.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Whang, William. "Coronary Heart Disease." In Encyclopedia of Behavioral Medicine. Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4614-6439-6_396-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Coronary heart disease – Chemotherapy"

1

Poniewierski, M., M. Barthels, and H. Poliwoda. "THE SAFETY AND EFFICACY OF A LOW MOLECULAR WEIGHT HEPARIN (FRAGMIN) IN THE PREVENTION OF DEEP VEIN THROMBOSIS IN MEDICAL PATIENTS: A RANDOMIZED DOUBLE-BLIND TRIAL." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643224.

Full text
Abstract:
The safety and efficacy of 2500 anti-Factor Xa U of a low molecular weight heparin (Kabi 2165, Fragmin) subcutaneously once a day, and 5000 IU of standard unfractionated Heparin (KabiVitrum, Stockholm) subcutaneously twice daily as thromboprophylaxis was compared in 200 medical patients in a randomized double blind trial. According to the risk of DVT the patients were stratified before randomization in a high and low risk group. The high risk group consisted of 100 patients mainly with malignant diseases and/or previous history of thromboembolism, the low risk group of 100 patients with mainly
APA, Harvard, Vancouver, ISO, and other styles
2

Lin, Shisong, Xiaodong Zhuang, Shiyun Huang, Yahui Liu, Linlin Shen, and Xinxue Liao. "Face Analysis for Coronary Heart Disease Diagnosis." In 2019 12th International Congress on Image and Signal Processing, BioMedical Engineering and Informatics (CISP-BMEI). IEEE, 2019. http://dx.doi.org/10.1109/cisp-bmei48845.2019.8966020.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Pareek, Vishakha, and R. K. Sharma. "Coronary heart disease detection from voice analysis." In 2016 IEEE Students' Conference on Electrical, Electronics and Computer Science (SCEECS). IEEE, 2016. http://dx.doi.org/10.1109/sceecs.2016.7509344.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Mangathayaru, Nimmala, B. Padmaja Rani, V. Janaki, Lakshmi Sowmya Kotturi, Manasa Vallabhapurapu, and G. Vikas. "Heart Rate Variability for Predicting Coronary Heart Disease using Photoplethysmography." In 2020 Fourth International Conference on I-SMAC (IoT in Social, Mobile, Analytics and Cloud) (I-SMAC). IEEE, 2020. http://dx.doi.org/10.1109/i-smac49090.2020.9243316.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Runjing, Zhou, and Li Keyang. "Fisher classifier in diagnosis of coronary heart disease." In 2011 4th International Congress on Image and Signal Processing (CISP). IEEE, 2011. http://dx.doi.org/10.1109/cisp.2011.6100787.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Gonsalves, Amanda H., Fadi Thabtah, Rami Mustafa A. Mohammad, and Gurpreet Singh. "Prediction of Coronary Heart Disease using Machine Learning." In the 2019 3rd International Conference. ACM Press, 2019. http://dx.doi.org/10.1145/3342999.3343015.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Li Xia, Fu Yifei, Bai Jing, Tian xin, and Li Fangjie. "Complexity analysis on heart rate variability of coronary heart disease patients." In 2008 International Conference on Technology and Applications in Biomedicine (ITAB). IEEE, 2008. http://dx.doi.org/10.1109/itab.2008.4570590.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

MISCHIE, Niculina, and Adriana ALBU. "Artificial Neural Networks for Diagnosis of Coronary Heart Disease." In 2020 International Conference on e-Health and Bioengineering (EHB). IEEE, 2020. http://dx.doi.org/10.1109/ehb50910.2020.9280271.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Khatibi, Vahid, and Gholam Ali Montazer. "Coronary heart disease risk assessment using dempster-shafer theory." In 2009 14th International CSI Computer Conference (CSICC 2009) (Postponed from July 2009). IEEE, 2009. http://dx.doi.org/10.1109/csicc.2009.5349607.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Widiyaningtyas, Triyanna, Ilham Ari Elbaith Zaeni, and Putri Yula Wahyuningrum. "Self-Organizing Map (SOM) For Diagnosis Coronary Heart Disease." In 2019 4th International Conference on Information Technology, Information Systems and Electrical Engineering (ICITISEE). IEEE, 2019. http://dx.doi.org/10.1109/icitisee48480.2019.9003746.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Coronary heart disease – Chemotherapy"

1

Dong, Guoqi, Mengye Lu, Xiaoliang Wu, Hao Chen, Hongru Zhang, and Yihuang Gu. Network meta-analysis of Traditional Chinese medicines for depression in coronary heart disease patients. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.5.0036.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Wienke, Andreas, Anne M. Herskind, Kaare Christensen, Axel Skytthe, and Anatoli I. Yashin. The influence of smoking and BMI on heritability in susceptibility to coronary heart disease. Max Planck Institute for Demographic Research, 2002. http://dx.doi.org/10.4054/mpidr-wp-2002-003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Cai, Ruping, Yuli Xu, and Qiang Su. Meta-analysis of blood lipid reduction for patients with coronary heart disease by combination of pitavastatin and ezetimibe. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.5.0072.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ghambaryan, Anna. Heart Rate Variability, Catecholamine and Hemodynamic Responses During Rest and Stress in Coronary Artery Disease Patients: The PIMI Study. Defense Technical Information Center, 2007. http://dx.doi.org/10.21236/ad1013978.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Pan, JianLue, Pangning Huang, Yuanwen Zhang, RongFa Huang, QiuCen Chen, and HuiBing Chen. Commonly Traditional Chinese Medicine in treatment of Coronary Atherosclerotic Heart Disease with Anxiety and Depression: a network meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.4.0124.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Liu, Chao, Jing Bai, Lanchun Liu, Jialiang Gao, and Jie Wang. Effectiveness and safety of Yufengningxin for treating coronary heart disease angina: A protocol for a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.11.0040.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Wang, Lina, Yangli Sun, Jie Zhan, et al. Effects of exercise therapy on anxiety and depression in patients with coronary heart disease: a meta-analysis of a randomized controlled study. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.6.0017.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Fan, Maoxia, Ying Tian, and Dong Guo. Efficacy and safety of Xinkeshu in the treatment of angina pectoris of coronary heart disease: A systematic review and meta-analysis protocol. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.9.0026.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Li, Xing-xing, Zong-jing Fan, Jie Cui, et al. Cardiac rehabilitation of Baduanjin exercise in coronary heart disease after PCI: a protocol for systematic review and meta-analysis of randomized controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.3.0065.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Xu, Xiangmei, Wenna Yang, Xuan Chen, Yixuan Kong, Jie Wang, and Jinghui Zheng. Traditional Chinese Medicine Injection Combined with Conventional Western Medicine in Treating Coronary Heart Disease after PCI:A Protocol systematic review and meta analysis of overview. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.7.0087.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!